Acceleration of the interleukin-1 receptor antagonist (IL-1Ra) trajectory precedes the diagnosis of type 2 diabetes by 6 years: the Whitehall II prospective cohort study
Journal article published in 2009 by
M. Carstensen,
C. Herder,
M. Kivimaki,
M. Jokela,
M. Roden,
M. Shipley,
Dr Witte 
,
Ej Brunner,
Ar Tabak
,
Ej Brunner,
Ar Tabak
